Growth Metrics

Heron Therapeutics (HRTX) Long-Term Deferred Tax (2017)

Heron Therapeutics (HRTX) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $3.6 million as the latest value for Q3 2017.